Automation index

How much of a Trader’s job can AI already do?

An order book comes earlier. Executing without blowing the price do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

27%

AI can already do 27% of this job.

#195 / 643

Trader

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Book, liquidity and the ticket. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Execute, slippage and the one who panics. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Limits, risk and not blowing them. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Close, P&L and not hiding the loss. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
The rumour, the news and not chasing. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Execute clean, and not blowing the price. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

27%

#168 / 643

Immunologist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Panel, autoantibodies and the report. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Clinic, the flare and the one that does not fit. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Immunosuppressant, the dose and not dropping extra. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Infection, the risk and vaccinating on time. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
The internist, the board and not delaying the biologic. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Call it autoimmune, and sign the treatment. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low